Anti-angiogenic Targets HER2/EGFR Targets Nuclear Receptors Hormone receptors Heme surface markers Other surface markers Bcr/abl Proteosome inhibitors PPAR gamma PARP Methylation Immune therapies Cytokines mTOR wynt/apc IGF, survival, PI3K, AKT Anti-angiogenic Targets HER2/EGFR Targets Nuclear Receptors Hormone receptors Heme surface markers Other surface markers Bcr/abl Proteosome inhibitors PPAR gamma PARP Methylation Immune therapies Cytokines mTOR wynt/apc IGF, survival, PI3K, AKT ukryj opis